Home » Topics » Regulatory

Regulatory
RSS

Maruho's Zebiax approved in Japan for bacterial skin infections

Sep. 30, 2015

Shionogi's Mulpleta approved in Japan for thrombocytopenia

Sep. 29, 2015

GlaxoSmithKline's Zagallo receives approval in Japan

Sep. 29, 2015

Japan first country to approve omarigliptin

Sep. 28, 2015

VivaGel BV approved in E.U. for bacterial vaginosis

Sep. 25, 2015

LFB's IVIg Iqymune approved in U.K. and Denmark

Sep. 22, 2015

FDA approves Vraylar for bipolar disorder and schizophrenia

Sep. 18, 2015

Santhera receives European approval for Raxone in Leber's hereditary optic neuropathy

Sep. 10, 2015

Terumo's autologous skeletal myoblast sheets approved in Japan for heart failure

Sep. 7, 2015

FDA approves Xuriden for hereditary orotic aciduria

Sep. 7, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ASH 2025: New blood cancer therapies trump chemo, older drugs
BioWorld
Targeted therapies and immunotherapies continue to show better results than chemotherapy in investigator-initiated and company-sponsored cancer trials, and newer...